Mediator stabilized reagent compositions for use in biosensor electrodes

• US 8,696,884 B2
• Filed: 04/02/2012
• Issued: 04/15/2014
• Est. Priority Date: 10/12/2007
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Forrow, Nigel J.
• Primary Examiner(s): Van, Luan
• Assistant Examiner(s): ROSENWALD, STEVEN ERIC
• Application Number:
  US13/437,694
• Publication Number:
  US 20120325679A1
• Time in Patent Office: 743 Days
• Field of Search: 204/402, 204/403.01
• US Class Current: 205/777.5
• CPC Class Codes: C12Q 1/004 mediator-assisted
• CPC Class Codes: C12Q 1/006 for glucose

Abstract

The claimed subject matter relates to the stabilization of 1,2-quinone mediators, especially those containing 1,10-phenanthroline quinone (PQ) and more especially transition metal complexes of PQ, in the presence of enzymes when contained in dry reagent layers for biosensor electrodes, through the use of various metal salts, particularly those of lithium.

Claims

1. A method of determining concentration of an analyte, the method comprising:

contacting a sample with a biosensor strip comprising;

an electrode support;

a working electrode disposed on the electrode support;

a reference electrode disposed on the electrode support;

a reagent composition deposited on at least one of the working electrode and the reference electrode, wherein the reagent composition comprises;

an enzyme, and

a redox mediator complex comprising;

a first metal ion covalently bonded to at least one compound comprising a 1,2-quinone moiety; and

a second metal ion non-covalently bonded to the oxygen atoms of the 1,2-quinone moiety;

applying a potential to the working electrode;

measuring a current from the working electrode; and

determining the analyte concentration.

2. The method according to claim 1, wherein the applied potential to the working electrode ranges from −

0.4 V to 0.4 V.

3. The method according to claim 2, wherein the applied potential to the working electrode is 200 mV.

4. The method according to claim 1, wherein the measured current is proportional to the analyte concentration.

5. The method according to claim 1, wherein the at least one compound comprising a 1,2-quinone moiety is 1,10-phenanthroline quinone, or a derivative thereof.

6. The method according to claim 1, wherein the first metal ion is selected from the group consisting of nickel, manganese, iron, cobalt, osmium or ruthenium.

7. The method according to claim 1, wherein the second metal ion is selected from the group consisting of lithium, scandium, yttrium, lanthanum, cerium, praseodymium, neodymium, promethium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium ytterbium and lutetium.

8. The method according to claim 7, wherein the second metal ion is lithium.

9. The method according to claim 1, wherein the redox mediator complex comprises [Ni(PQ₃)]²⁺.

10. The method according to claim 1, wherein the enzyme is selected from the group consisting of an NAD(P)+-dependent dehydrogenase, a PQQ-glucose dehydrogenase, an FAD-glucose dehydrogenase, a hydroxybutyrate dehydrogenase and a glucose oxidase.

11. The method according to claim 1, wherein the reagent composition is deposited on the working electrode and the reference electrode.

12. The method according to claim 1, wherein the analyte is selected from the group consisting of glucose, ketone bodies, cholesterol and lactate.

13. The method according claim 12, wherein the analyte is glucose.

14. The method according to claim 12, wherein the analyte are ketone bodies.

15. The method according to claim 1, wherein the first metal ion is a transition metal and the second metal ion is a lanthanide.

16. The method according to claim 1, wherein the first metal ion and second metal ion are different.